Federal Data HubHRSA 340B · JSON

CUMBERLAND DIAGNOSTIC & TREATMENT CENTER

340B ID HV021430

Not participatingHV

CUMBERLAND DIAGNOSTIC & TREATMENT CENTER is a HV enrolled in the federal 340B Drug Pricing Program in BROOKLYN, NY. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 24 contract-pharmacy arrangement(s) (0 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (24)

PharmacyLocationBeginTerminatedPharmacy ID
31ST & 3RD PHARMACY INCMELVILLE, NY2018-07-012018-10-0121254
ACCREDO HEALTH GROUP INCWARRENDALE, PA2018-07-012018-10-0123041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2018-07-012018-10-0145979
ACCREDO HEALTH GROUP, INC.NEWARK, DE2018-07-012018-10-0198337
ACCREDO HEALTH GROUP, INC.ORLANDO, FL2018-07-012018-10-0139194
ACCREDO HEALTH GROUP, INC.INDIANAPOLIS, IN2018-07-012018-10-0151763
DUANE READEBROOKLYN, NY2018-07-012018-10-015784
DUANE READEBROOKLYN, NY2018-07-012018-10-0119743
DUANE READEBROOKLYN, NY2018-07-012018-10-019460
EXPRESS HEALTH MART PHARMACY CORP.BROOKLYN, NY2018-07-012018-10-0187949
EXPRESS SCRIPTS PHARMACY, INC.BURLINGTON, NJ2018-10-012018-10-0192471
GOLD STREET PHARMA INC.BROOKLYN, NY2018-07-012018-10-0119752
MARG PHARMACYBROOKLYN, NY2018-07-012018-10-01924
MYRTLE PHARMACY INCBROOKLYN, NY2018-07-012018-10-0119802
PHARMACIA POPULAR INCBROOKLYN, NY2018-07-012018-10-0119829
RITE AID OF NEW YORK, INC.BROOKLYN, NY2018-07-012018-10-019711
WALGREEN EASTERN CO., INC.BROOKLYN, NY2018-07-012018-10-019406
WALGREEN EASTERN CO., INC.BROOKLYN, NY2018-07-012018-10-019459
WALGREEN EASTERN CO., INC.BROOKLYN, NY2018-07-012018-10-0187183
WALGREENS MAIL SERVICE, LLCTEMPE, AZ2018-07-012018-10-01109700
WALGREENS.COM, INC.CHANDLER, AZ2018-07-012018-10-01108290
WOODHULL PRESCRIPTION CENTERBROOKLYN, NY2018-07-012018-10-0119818
WYCKOFF PHARMACY INC.BROOKLYN, NY2018-07-012018-07-1219827
WZ PREMIUM INC.BROOKLYN, NY2018-07-012018-10-01105154

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.